Find Academic Supervisors

Barbara ConwayView profile

Professor

• Pharmaceutics
• Drug Delivery
• Antimicrobials
• +7 more

Barbara Conway is a Professor and Head of Pharmacy at the University of Huddersfield, leading the Department of Pharmacy within the School of Applied Sciences. She holds additional roles as Co-Director of the Institute of Skin Integrity and Infection Prevention and Director of the Pharmaceutics and Drug Delivery Centre. Her expertise spans pharmaceutics, drug delivery systems, antimicrobial stewardship, and wound healing innovations. She has supervised over 60 PhD students and maintains active collaborations with NHS institutions and pharmaceutical industries. Her research focuses on improving skin antisepsis, antimicrobial delivery, and solubility enhancement for poorly soluble drugs. Key achievements include patents in pharmaceutical formulations and recognition as a Fellow of the Higher Education Academy and Medici Fellow. Recent work explores nanotechnology applications in drug delivery, 3D-printed formulations, and dissolution imaging technologies. Dr. Conway has published extensively, with notable contributions in Journal of Drug Delivery Science and Technology , Pharmaceutics , and European Journal of Pharmaceutics and Biopharmaceutics . She actively participates in conferences, including roles as a keynote speaker and session chair at Wounds Week and international drug delivery symposiums. Her work aligns with UN Sustainable Development Goals, particularly addressing global health challenges through innovative pharmaceutical solutions. Professional accolades include the Platinum Award at the 2017 Atomic Force Microscope Conference and multiple patents. She advocates for interdisciplinary approaches, combining materials science, nanotechnology, and clinical pharmacy to advance healthcare outcomes.

Alex AdronovView profile

Adjunct Professor

• Polymer Synthesis
• Macromolecular Architectures
• Dendrimers
• +9 more

Alex Adronov is an Adjunct Professor and Associate Member of the McMaster School of Biomedical Engineering at McMaster University. His research focuses on polymer synthesis and nanomaterials, particularly dendrimers, carbon nanotubes, and their applications in drug delivery, biomaterials, and biomedical devices. He leads the Adronov Group, which explores molecular architectures and nanoscale structures for real-world applications such as molecular electronics and medical therapeutics. His work emphasizes organic synthesis and structure-property relationships in polymers and nanomaterials. Research Interests: His primary areas include polymer therapeutics, nanomaterials for biomedical applications, carbon nanotube chemistry, and functional biomaterials. He investigates novel materials for drug delivery systems, wearable sensors, and energy storage devices, leveraging both synthetic chemistry and advanced characterization techniques. Publications: Dr. Adronov's recent work highlights advancements in carbon nanotube-based sensors, self-immolative polymers for nanotube dispersion, and drug delivery platforms using dendrimers and cyclodextrin complexes. His research spans interdisciplinary fields, including materials science, biomedical engineering, and chemical engineering. Labs/Teams: The Adronov Group collaborates with interdisciplinary teams at McMaster, focusing on translating nanomaterial innovations into practical solutions for healthcare and engineering challenges.

• Medical Imaging
• Biomedical Engineering
• Materials Science
• +5 more

Caroline De Gracia Lux is an Assistant Professor in the Department of Radiology at UT Southwestern Medical Center, affiliated with the Translational Research in Ultrasound Theranostics program. She holds a Ph.D. in Chemistry from the University of Strasbourg and completed postdoctoral training at UCSD, focusing on biocompatible materials for theranostic applications. She also earned a Micro-MBA from UCSD’s Rady School of Management, emphasizing leadership and strategic communication. Her research integrates synthetic chemistry and formulation to develop advanced ultrasound contrast agents and nanomedicines for cancer imaging and treatment. Key areas include stabilizing low-boiling-point perfluorocarbon emulsions, activatable contrast agents, and multimodal imaging probes. Her work emphasizes translational applications, such as macrophage imaging via acoustic vaporization of nanodroplets and pH-responsive microbubble systems for targeted therapy. Education: Ph.D. in Chemistry, University of Strasbourg Micro-MBA (Rady School of Management, UCSD) Postdoctoral Training, UCSD (Polymeric Materials) Dr. Lux’s publications highlight innovations in nanodroplet emulsification, perfluorocarbon applications, and stimuli-responsive drug delivery systems. Her lab focuses on advancing ultrasound-based theranostics, with recent work exploring lipid microparticle phantoms for liver fat quantification and macrophage-stimulating perfluorocarbon emulsions. Key Contributions: Development of direct emulsification techniques for stable nanodroplets Design of pH-responsive microbubbles for ultrasound imaging Investigations into macrophage modulation via acoustic vaporization Her lab, the de Gracia Lux Lab, collaborates on cutting-edge projects at the intersection of chemistry, engineering, and clinical medicine, aiming to translate nanotechnology into clinical diagnostics and therapies.

Mihai CovasaView profile

Professor

• Obesity Research
• Diabetes
• Nutritional Neuroscience
• +3 more

Mihai Covasa, Ph.D., is a Professor of Physiology at the Western University of Health Sciences , specifically within the College of Osteopathic Medicine of the Pacific . He holds a Ph.D. in Physiology and Nutrition from the University of Leeds (1994) and has extensive postdoctoral and academic experience, including roles at The Pennsylvania State University and Washington State University. His research focuses on obesity, diabetes, and gut microbiota , investigating mechanisms linking dietary fats, neural regulation, and metabolic dysfunction. Education: Ph.D. Physiology and Nutrition, University of Leeds, UK (1994) M.S. Physiology and Nutrition, University of Leeds, UK (1992) B.S. Honors Animal Science, University of Iasi, Romania (Year not specified) Research Interests: Neural control of eating behavior and body weight regulation Role of gut microbiota in metabolic health and disease Impact of dietary fats on obesity and type 2 diabetes Postoral nutrient signaling and satiety mechanisms Recent Work Trends: Dr. Covasa’s publications emphasize gut microbiota manipulation (e.g., probiotics, fecal transplants) as therapeutic strategies for metabolic disorders. His studies also explore long COVID-19 mechanisms and wastewater-based epidemiology for public health monitoring. Labs/Teams: His research group investigates the microbiota-gut-brain axis and employs rodent models to study obesity and diabetes. Collaborations include work on biopolymer drug delivery systems for diabetes management and genomic surveillance of viral outbreaks.

Todd HoareView profile

Professor

• Biomaterials Engineering
• Polymer Science
• Drug Delivery
• +7 more

Todd Hoare is a Professor in the Department of Chemical Engineering at McMaster University and holds the Canada Research Chair in Engineered Smart Materials. He is the Director of the NSERC CREATE Training Program for Controlled Release Leaders (ContRoL) and an Associate Member of the McMaster School of Biomedical Engineering. His research focuses on designing smart hydrogel-based materials for biomedical, environmental, and industrial applications, particularly in drug delivery, tissue engineering, and nanotechnology. Dr. Hoare has received prestigious awards including the NSERC Steacie Fellowship (2018) and the John Charles Polanyi Prize in Chemistry (2009). Education B.Sc. (Eng), Engineering Chemistry, Queen’s University (2001) Ph.D., Chemical Engineering, McMaster University (2006) Post-Doctoral Fellow, Langer Lab, MIT (2006-2008) Research Interests Dr. Hoare’s work bridges polymer science, physical chemistry, and biology to engineer hydrogels for applications ranging from drug delivery and biosensors to agricultural and environmental solutions. His lab emphasizes rational design based on structure-property relationships, with a focus on in situ-gelling systems, nanoscale drug carriers, and stimuli-responsive materials. Grants & Collaborations Recipient of a $1.65M NSERC training grant (2021) for interdisciplinary education. Secured CIHR funding ($1M+) for research on osteoarthritis and age-related macular degeneration (2025). Leading a multi-institutional team awarded the Brockhouse Canada Prize (2023) for vision health research. Labs & Editorial Roles Director of the Hoare Lab, which hosts the NSERC ContRoL program. He serves as Executive-Editor of Chemical Engineering Journal and on the editorial board of Biomacromolecules .

Swadeshmukul SantraView profile

Professor

• Nanoscience
• Nanotechnology
• Nano-Agriculture
• +5 more

Swadeshmukul Santra, Ph.D., is a Professor at the University of Central Florida with joint appointments in the NanoScience Technology Center and Department of Chemistry. As founding director of the UCF Materials Innovation for Sustainable Agriculture (MISA) Center, his work focuses on nanotechnology applications in agriculture and medicine. His research addresses crop protection through nanomaterials like nano-pesticides and nano-fertilizers, as well as nanomedicine innovations such as drug delivery systems and bioimaging probes. Dr. Santra has secured over $6 million in grants from NSF, USDA, and industry partners, and holds 35 patents. His nano-agriculture projects target citrus diseases like greening and canker, while nanomedicine efforts explore targeted therapy delivery. Notable collaborations include developing zinc oxide-based formulations (Zinkicide) for plant vascular pathogens and silk-based microneedles for drug delivery. Research Interests: Engineered nanomaterials, nanobioimaging, nanotoxicology, nano-pesticides, and sustainable agricultural technologies. Key Projects: Citrus disease management, antimicrobial nanocomposites, and FAIR database systems for bacterial identification (BacteSign). Grants & Awards: Over $6M funding from NSF/USDA; 35 issued patents (28 U.S.-based). His lab emphasizes translational research, with technologies under evaluation by multinational agrochemical companies. Commercialization efforts include partnerships with UCF’s Office of Research and Commercialization for startup opportunities in quantum dot imaging and nano-fertilizer platforms.

Valentyn MohylyukView profile

Researcher

• Pharmaceutical Technology
• Drug Delivery Systems
• Formulation Science
• +4 more

Dr. Valentyn Mohylyuk is a pharmaceutical scientist serving as Lead Researcher and Scientific Project Manager at Riga Stradiņš University's pharmaceutical scientific group. He holds a BS/MS in Pharmaceutical Technology and a PhD in Pharmaceutical Science. His career spans academic and industrial roles, including positions at Freie Universität Berlin, University of Hertfordshire, and Queen's University Belfast. His research focuses on formulation science, drug delivery systems, and advanced manufacturing techniques like 3D printing and hot-melt extrusion. Key interests include enhancing drug solubility/bioavailability, developing abuse-deterrent formulations, and continuous manufacturing processes. Education: PhD in Pharmaceutical Science (Year unspecified) BS/MS in Pharmaceutical Technology (Year unspecified) Research Interests: Oral dosage form development with tailored drug release profiles Amorphous solid dispersions and polymer-based formulations 3D printing (FDM) for personalized dosage forms Continuous manufacturing via extrusion and roll compaction Biopharmaceutical permeability studies Articles Trends: Recent work emphasizes 3D printing applications, polymer-drug interactions in amorphous systems, and melt granulation optimization. Key themes include overcoming solubility challenges and advancing manufacturing technologies. Scientific Awards: Letter of Appreciation from the President of the Latvian Academy of Sciences (2024) Grants/Advising: Active projects include sugar alcohol binders in melt granulation (EU-funded) and amorphization mechanisms (Latvian Council) Advising on student projects like solvent effects in solid dispersions Labs/Teams: Leads Riga Stradiņš University's pharmaceutical research group, collaborating internationally on formulation science and advanced manufacturing.

Līga PētersoneView profile

Researcher

• Pharmaceutical Chemistry
• Drug Delivery Systems
• Tablet Formulation
• +3 more

Līga Pētersone is a Researcher and Project Manager at Rīga Stradiņš University , focusing on pharmaceutical chemistry and drug delivery systems. She leads innovative projects such as biowaste valorization into health-promoting agents and advanced tablet formulation techniques using polyols. Her research emphasizes solid dosage forms , dissolution testing , and melt granulation , with recent publications in Pharmaceutics and Journal of Pharmaceutical Sciences . She collaborates extensively with researchers like V. Mohylyuk and E. M. Buczkowska. Scientific Awards Letter of Appreciation from the President of the Latvian Academy of Sciences (2024) Līga mentors students such as Žogota, M. , Gurkina, K. , and Mahinovs, R. , and participates in peer-review activities for journals like ACS Sustainable Resource Management and Foods .

Deji AremuView profile

Lecturer

• Additive Manufacturing
• Mechanical Engineering
• Materials Science
• +8 more

Deji Aremu is a Lecturer in Mechanical Engineering at the CEES School of Engineering. He holds a Doctorate in Mechanical and Manufacturing Engineering from Loughborough University, specializing in Topology Optimization for Additive Manufacturing, alongside an MSc in Manufacturing Systems Engineering from the University of Warwick and a degree in Metallurgical and Material Engineering from Obafemi Awolowo University. His research focuses on additive manufacturing, composites, and finite element analysis, with notable contributions to machine learning applications in materials science. Education: Doctorate in Mechanical and Manufacturing Engineering (2009–2013), Loughborough University MSc in Manufacturing Systems Engineering (2006–2007), University of Warwick Bachelor’s in Metallurgical and Material Engineering (1998–2005), Obafemi Awolowo University His research interests include additive manufacturing techniques, mechanical properties of composite materials, lattice structures, and structural optimization. He employs machine learning to enhance parameter optimization and predictive modeling in materials processing. Recent work explores porosity effects in thermoplastic composites and crashworthiness of polymer-based honeycomb structures. Dr. Aremu supervises PhD projects on additive manufacturing for developing nations, algorithm development for lattice structures, and material design for cost-effective metal AM processes. He actively collaborates on global engineering challenges, particularly leveraging AM for third-world infrastructure solutions.

Heidi MansourView profile

Professor

• Targeted Drug Delivery
• Nanomedicine
• Translational Medicine
• +3 more

Dr. Heidi Mansour is a tenured Full Professor at Florida International University (FIU), holding appointments in the Robert Stempel College of Public Health and Social Work (Department of Environmental Health Sciences), Herbert Wertheim College of Medicine (Department of Cellular and Molecular Medicine), and the College of Engineering (Department of Biomedical Engineering). She leads the Drug Discovery and Delivery Program at FIU’s Center for Translational Science. Her research focuses on targeted drug delivery systems, nanomedicine, and inhalation aerosols for pulmonary and vascular diseases. She is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE) and a Senior Member of the National Academy of Inventors (NAI). Dr. Mansour’s education includes a PhD in Pharmaceutical Sciences and a pharmacy degree from the University of Wisconsin-Madison, followed by postdoctoral training at UW-Madison and UNC-Chapel Hill. She has secured NIH grants and pioneered over 100 publications, 10 patents, and 16 book chapters. Her work has trained 5 PhD students and 15 postdocs, many of whom now lead roles in academia and industry. Key research areas include multifunctional nanocarriers for lung surfactants, nose-to-brain non-invasive delivery, and biodegradable polymers for sustained drug release. She serves on editorial boards of journals like RSC Molecular Systems Design & Engineering and co-edited books on inhalation aerosol medicine. Current projects address pulmonary hypertension, anti-inflammatory therapies, and translational nanomedicine. Awards: 2022 AIMBE Fellow (for targeted pulmonary inhalation innovations), 2023 NAI Senior Member. Lab: Mansour Lab. Active in professional organizations including the American Thoracic Society and PhRMA Foundation Scientific Advisory Committee.

• Nanotechnology
• Drug Delivery Systems
• Nanoparticle-Bio Interactions
• +2 more

Dr. Grzegorz Gołuński is a Lecturer at the University of Gdańsk's Intercollegiate Faculty of Biotechnology, affiliated with the Institute of Biotechnology. His research focuses on nanobiotechnology applications in medicine, particularly nanoparticle-drug interactions and modulation of therapeutic agents. Primary research areas include: Design and characterization of metal nanoparticles (Pt, Ag) for drug delivery Modulation of antibiotic and anticancer drug efficacy using nanomaterials Biophysical analysis of nanoparticle-biological system interactions Development of nano-carrier systems for enhanced therapeutic delivery Recent publications demonstrate consistent focus on platinum and silver nanoparticles as modulators of chemotherapeutic agents (doxorubicin, cisplatin, daunorubicin), with additional research on caffeine's role in enhancing antibiotic activity and fullerene-based drug delivery systems.

Sheng QiView profile

Professor

• Pharmaceutical Materials Science
• Drug Delivery Systems
• Solid-State Characterization
• +5 more

Sheng Qi is a Professor of Pharmaceutical Material Science and Technology at the School of Chemistry, Pharmacy and Pharmacology , University of East Anglia. With a BEng (2001) and PhD (2004) in pharmacy-related fields, her 20-year academic career includes roles from postdoctoral scientist to senior lecturer (2013). She collaborates with global pharmaceutical companies on drug delivery systems, material science, and process engineering. Industrial partnerships with Evonik Industries, Uropharma Ltd, and Innovate UK Editorial role in "3D Printing of Pharmaceutical and Drug Delivery Devices" book Keynote speaker at international conferences since 2013 Research Focus: Fundamental understanding of drug-polymer/lipid dispersions in both solid and liquid states, with emphasis on stabilizing supersaturated drug systems. Her work integrates material science principles with pharmaceutical applications to enhance drug absorption through physical chemistry optimization. Article Trends: Active in 3D printing applications (10+ papers 2021-2024) with focus on shape-memory polymers, polypill design, and geometric release control. Recent work spans anti-pollution cosmetics (2025), implantable drug systems (2023), and advanced characterization techniques like spatial NMR (2025). Awards: 2025 UEA Innovation and Impact Award (Knowledge Exchange Project of the Year) Funding Leadership: Principal Investigator in 8+ projects totaling £1.5M+ since 2009, including INTERREG EU grants and Royal Society awards. Current projects (2023-2025) cover antimicrobial resistance, digital technology training, and personalized medicine. Collaborative Networks: Active in UN Sustainable Development Goals related to health. International collaborations include Germany (Evonik), Czech Republic (Prague workshops), and multiple UK institutions.

Matteo GigliView profile

Associate Professor

• Green Chemistry
• Sustainable Materials
• Nanotechnology
• +4 more

Matteo Gigli is an Associate Professor at the Department of Molecular Sciences and Nanosystems , Ca' Foscari University of Venice. His research focuses on sustainable materials development, biomass valorization, and green chemistry applications through projects like PRIMA program's QuiPack and EU-funded TURBOPACK. Supervises the Safety Laboratory at the Scientific Campus (via Torino) Editorial board member of Frontiers in Chemistry (Green and Sustainable Chemistry section) Reviewer for 30+ journals including ACS Sustainable Chemistry & Engineering and Journal of Membrane Science Research areas include: Green Chemistry (lignin-based nanocarriers, rice husk silica) Biomaterials (chitin nanocrystal films, biodegradable polymers) Environmental Engineering (photodegradation of antibiotics, water purification) Teaching activities include: Master's course: Bio-plastics for Sustainable Applications Bachelor's courses: Inorganic Chemistry and Inorganic Chemistry Laboratory

• Ionic Liquids
• Drug Delivery
• Nanomaterials
• +2 more

Dr. Eden Tanner is an Assistant Professor of Chemistry and Biochemistry at the University of Mississippi, leading the Tanner Lab. She holds a B.Sc. in Advanced Science (Chemistry) from the University of New South Wales, a Ph.D. in Physical and Theoretical Chemistry from the University of Oxford, and completed postdoctoral research at Harvard University. Her work focuses on drug delivery systems using ionic liquids and nanomaterials, particularly for biomedical applications such as nanoparticle-based therapies and overcoming biological barriers like the blood-brain barrier. Her research interests include ionic liquids, drug delivery mechanisms, nanomaterial synthesis, and their applications in cancer therapy, neuroHIV treatment, and photothermal therapy. She teaches General Chemistry courses (CHEM 105/106) and emphasizes making chemistry accessible through innovative laboratory instruction. The Tanner Lab collaborates across disciplines, integrating physical chemistry with bioengineering to address unmet clinical needs. Dr. Tanner’s publications highlight advancements in nanoparticle design, surface functionalization strategies, and the development of responsive drug delivery systems. She has pioneered approaches like protein-avoidant ionic liquid (PAIL)-coated nanoparticles to enhance circulation time and target specificity. Her work also explores transdermal and topical delivery mechanisms using ionic liquids, alongside applications in antimicrobial therapies and diagnostic sensing technologies.

• Chemistry Education
• Membrane Biophysics
• Solid-State NMR Spectroscopy
• +6 more

Dr. Deborah Gater serves as an Assistant Professor of Chemistry and Associate Director for Enrolment Management at Northeastern University London, part of the CoMENS Faculty. She holds dual Master’s degrees (Chemistry and Protein/Membrane Chemical Biology) and a PhD in Chemistry from Imperial College London. Her research bridges membrane biophysics, solid-state NMR, and educational innovation, focusing on cholesterol-membrane interactions and technology-enhanced chemistry teaching. She previously worked at Khalifa University and UCL’s Centre for Languages and International Education. Her research explores cholesterol’s role in membrane systems, semiconductor-based biosensors, and vitamin D’s effects on membranes. She collaborates across disciplines to advance biophysical techniques and educational accessibility. Teaching areas include general/organic chemistry and drug discovery for apprenticeships. Key Research Areas : Membrane biophysics, solid-state NMR, amino acid detection via GaAs sensors, vitamin delivery systems, and evidence-based teaching methods. Notable Projects : Development of transdermal vitamin D3 systems, chip-based biochemical sensors, and Moodle-based online assessment analytics. Locations : Based at Northeastern’s London campus (Devon House, E1W 1LP). Dr. Gater’s work emphasizes interdisciplinary collaboration, with publications spanning chemical education, biophysical methods, and material science applications. Her teaching innovations address inclusivity and technology integration in STEM education.